Founder and CEO, BioViva
Liz Parrish founded BioViva, a company committed to extending healthy lifespans using cell technologies. She believes that we cannot cure the symptoms of ageing without treating the underlying cause. Cellular degeneration underlies biological ageing and is behind the development of Alzheimer’s, heart disease, renal failure amongst others.
In 2015 Liz became the first person in the world to take dual gene therapies to treat ageing. She is known as “the woman who wants to genetically engineer you,” and is a humanitarian, entrepreneur and innovator, and a leading voice for regenerative medicine. She is also the founder of BioTrove Investments and BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine.